Legal News

Competition monthly highlights—January 2018

Published on: 31 January 2018
Published by: LexisPSL
  • Competition monthly highlights—January 2018
  • In this issue:
  • EU antitrust
  • Qualcomm fined €997m for abuse of dominant market position
  • Novartis’ and Roche’s agreement to manipulate the perceived risks of one drug over another constitutes an ‘object’ restriction
  • Commission extends its paid-TV investigation to include an additional subsidiary of NBCUniversal
  • Commission confirms dawn raids in kraft paper sector
  • EU mergers
  • Advocate General proposes that EUMR standstill obligation should not apply to measure that precedes and is severable from concentration
  • Acquisition of NXP by Qualcomm conditionally cleared
  • More...

Article summary

This month’s edition of Competition highlights include: (1) the Commission fining Qualcomm €997m for abusing its dominant position in the market for LTE baseband chipsets (2) the Court of Justice’s judgment in Hoffman, which ruled that an agreement to manipulate the perceived risks of one drug over another constitutes an ‘object’ restriction and (3) AG Wahl’s opinion in Ernst & Young, which proposed that the EUMR standstill obligation should not apply to a measure that precedes and is severable from a concentration or take a trial to read the full analysis.

Popular documents